miR-203a regulates proliferation, migration, and apoptosis by targeting glycogen synthase kinase-3β in human renal cell carcinoma

Klotho suppresses tumor progression via inhibiting PI3K/Akt/GSK3β/Snail signaling in renal cell carcinoma

(2013) Yu Zhu et al.   CANCER SCIENCE

Glycogen synthase kinase 3 promotes p53 mRNA translation via phosphorylation of RNPC1

(2013) M. Zhang et al.   GENES & DEVELOPMENT

Glycogen synthase kinase 3 beta inhibits microRNA-183-96-182 cluster via the  -Catenin/TCF/LEF-1 pathway in gastric cancer cells

(2013) X. Tang et al.   NUCLEIC ACIDS RESEARCH

GSK3β controls epithelial–mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug

(2013) S-H Kao et al.   ONCOGENE

Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer

(2013) W Kong et al.   ONCOGENE

miR-203 Inhibits Cell Proliferation and Migration of Lung Cancer Cells by Targeting PKCα

(2013) Chen Wang et al.   PLoS One

MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transition

(2013) A J DeCastro et al.   Cell Death & Disease

MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin

(2012) Ka Bian et al.   FEBS LETTERS

MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells

(2012) Chen Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Comparative efficacy of vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) and mammalian target of rapamycin (mTOR) inhibitor as second-line therapy in patients with metastatic renal cell carcinoma after the failure of first-line VEGF TKI

(2012) Kwonoh Park et al.   MEDICAL ONCOLOGY

Epigenetic silencing of MIR203 in multiple myeloma

(2011) Kwan-Yeung Wong et al.   BRITISH JOURNAL OF HAEMATOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression

(2011) Jian Li et al.   CANCER LETTERS

microRNA-203 suppresses bladder cancer development by repressing bcl-w expression

(2011) Juanjie Bo et al.   FEBS Journal

Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses

(2011) Heba W. Z. Khella et al.   TUMOR BIOLOGY

Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis

(2010) Sharanjot Saini et al.   CLINICAL CANCER RESEARCH

MicroRNA control of signal transduction

(2010) Masafumi Inui et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Genome-Wide Promoter Analysis of the SOX4 Transcriptional Network in Prostate Cancer Cells

(2009) C. D. Scharer et al.   CANCER RESEARCH

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma

(2009) Mayuko Furuta et al.   CARCINOGENESIS

MicroRNA profiling of human kidney cancer subtypes

(2009) Petillo   INTERNATIONAL JOURNAL OF ONCOLOGY

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

(2009) Ulrich Wellner et al.   NATURE CELL BIOLOGY

Inhibition of GSK3 Phosphorylation of β-Catenin via Phosphorylated PPPSPXS Motifs of Wnt Coreceptor LRP6

(2009) Geng Wu et al.   PLoS One

GSK3: a multifaceted kinase in Wnt signaling

(2009) Dianqing Wu et al.   TRENDS IN BIOCHEMICAL SCIENCES

MicroRNA expression profiles of esophageal cancer

(2008) Andrew Feber et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY